Brief: Interpace Biosciences Announces Addition To Board Of Directors And Changes In Leadership
Jan 30 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES ADDITION TO BOARD OF
DIRECTORS
AND CHANGES IN LEADERSHIP
* INTERPACE BIOSCIENCES INC - JAMES EARLY, CFO ANNOUNCES
RETIREMENT
* INTERPACE BIOSCIENCES INC - FRED KNECHTEL, FORMERLY CFO OF
GENEWIZ, APPOINTED AS CFO
* INTERPACE BIOSCIENCES INC - RON ROCCA, CEO OF EXAGEN,
APPOINTED
TO BOARD
Source text for Eikon: ID:nGNX327kG3
Further company coverage: IDXG.O
((Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million